Key result
Memantine and spironolactone protect against distinct, independent pathways of retinal ganglion cell degeneration.
Why the study?
The exact relationship between the renin-angiotensin-aldosterone system and NMDA receptor-mediated signal in retinal ganglion cell death was unclear.
The study suggests there is no direct relationship between the RAAS and NMDA receptor-mediated signaling pathways in retinal ganglion cell death.
May link aldosterone to NMDA excitotoxicity in RGCs; hypothesis-generating for RAAS-targeted neuroprotection.
Purpose: Excitotoxicity, which is due to glutamate-induced toxic effects on the retinal ganglion cell (RGC), is one of several mechanisms of RGC loss. The renin-angiotensin-aldosterone system (RAAS) has also been implicated in RGC death. Therefore, it is important to determine the exact relationship between the RAAS and N-methyl-d-aspartate (NMDA) receptor-mediated signal in order to prevent RGC death. Methods: N-methyl-d-aspartate or aldosterone was injected into the vitreous body. After intravitreal injection of NMDA or aldosterone, animals were treated with spironolactone or memantine. Retinal damage was evaluated by measuring the number of RGCs at 4 weeks after local administration of aldosterone or at 2 weeks after local administration of NMDA. Vitreous humor levels of aldosterone were measured using enzyme immunoassay kits. Results: A significantly decreased number of RGCs were observed after intravitreal injection of NMDA. Although spironolactone did not show any neuroprotective effects, memantine significantly reduced NMDA-induced degeneration in the retina. Furthermore, a significant decrease in the number of RGCs was observed after an intravitreal injection of aldosterone. While memantine did not exhibit any neuroprotective effects, spironolactone caused a significant reduction in the aldosterone-induced degeneration in the retina. There was no change in the aldosterone concentration in the vitreous humor after an NMDA injection. Conclusion: Our findings indirectly show that there is no relationship between the RAAS and NMDA receptor-mediated signal with regard to RGC death.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2017) studied Retinal ganglion cell death. Spironolactone or memantine was evaluated on Number of retinal ganglion cells (RGCs) and vitreous humor levels of aldosterone. Memantine reduced NMDA-induced but not aldosterone-induced retinal degeneration, while spironolactone reduced aldosterone-induced but not NMDA-induced degeneration, showing no relationship between the two pathways.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: